Expanding Export Market With its recent TGA certification and manufacturing plant in West Java, Combiphar is positioned to expand its export footprint, particularly to Australia, creating opportunities to introduce new health products to international markets.

Product Innovation Focus Combiphar invests in R&D and nanotechnology to optimize bioavailability and bioequivalence of prescription drugs, enabling the company to develop advanced pharmaceutical formulations that meet global standards, which can attract partnerships with innovative ingredient suppliers.

Consumer Healthcare Growth The company’s transition into a modern consumer healthcare brand with over 200 over-the-counter products, including vitamins and personal care, offers sales opportunities in wellness segments and retail pharmacies seeking trusted local brands.

Digital Engagement Strategies Combiphar’s active use of digital marketing campaigns such as #JalanTerusIndonesia demonstrates its commitment to engaging consumers online, presenting potential avenues for digital collaboration or sponsored health awareness initiatives.

Reputable Brand Position Ranked second in Indonesia’s most reputable healthcare brands, Combiphar’s strong brand loyalty and customer experience focus make it an attractive partner for co-branding, distribution agreements, and joint marketing efforts within Indonesia’s growing healthcare sector.